Skip to main content
Clinical Trials/NCT05958589
NCT05958589
Completed
Phase 3

Efficacy and Safety of General Anesthesia With Caudal Block for Inguinal Hernioplasty in Children: a Randomized Controlled Trial

University of Novi Sad1 site in 1 country70 target enrollmentJanuary 8, 2022

Overview

Phase
Phase 3
Intervention
Caudal block with levobupivacaine
Conditions
Postoperative Pain
Sponsor
University of Novi Sad
Enrollment
70
Locations
1
Primary Endpoint
Postoperative pain
Status
Completed
Last Updated
last year

Overview

Brief Summary

This is a prospective, randomized, controlled clinical study designed to determine the effectiveness of caudal block combined with general anesthesia in providing intra- and postoperative analgesia, and its effect on hemodynamic stability and drug consumption.

Detailed Description

This prospective, randomized, controlled clinical study will include 70 boys aged 3-5 years scheduled for inguinal herniorrhaphy. Participants will be randomized in 1:1 ratio into two groups. The first group will receive general anesthesia for surgery, while the second group will receive general anesthesia in combination with caudal block. Postoperative pain, hemodynamic parameters and total consumption of all medicaments in the perioperative period will be monitored. Complications and side effects of drugs will be observed as well.

Registry
clinicaltrials.gov
Start Date
January 8, 2022
End Date
July 20, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mihaela Preveden

Research Assistant

University of Novi Sad

Eligibility Criteria

Inclusion Criteria

  • boys between 3 to 5 years old
  • scheduled for elective inguinal hernioplasty
  • without comorbidities and chronic therapy, ASA class I
  • body mass and growth normal for the given age
  • no allergies
  • no congenital anomalies and birth complications

Exclusion Criteria

  • emergency surgeries
  • surgeries longer than 60 minutes
  • acute infections with leucocytosis/leucopenia
  • acute or chronic diseases
  • deformities and disorders of spine and nervous system
  • allergies
  • pilonidal cyst and/or inflammation in sacral region

Arms & Interventions

General anesthesia + caudal block

General anesthesia with intravenous anesthetic propofol (2-3 mg/kg), opioid analgesic fentanyl (1-1.5 mcg/kg), and muscle relaxant rocuronium - bromide (0.6-1 mg/kg), in combination with a single shot caudal block with levobupivacaine 0.25% (2.5 mg/kg; maximal dose 75 mg).

Intervention: Caudal block with levobupivacaine

General anesthesia + caudal block

General anesthesia with intravenous anesthetic propofol (2-3 mg/kg), opioid analgesic fentanyl (1-1.5 mcg/kg), and muscle relaxant rocuronium - bromide (0.6-1 mg/kg), in combination with a single shot caudal block with levobupivacaine 0.25% (2.5 mg/kg; maximal dose 75 mg).

Intervention: General anesthesia

General anesthesia + caudal block

General anesthesia with intravenous anesthetic propofol (2-3 mg/kg), opioid analgesic fentanyl (1-1.5 mcg/kg), and muscle relaxant rocuronium - bromide (0.6-1 mg/kg), in combination with a single shot caudal block with levobupivacaine 0.25% (2.5 mg/kg; maximal dose 75 mg).

Intervention: Inguinal hernioplasty

General anesthesia

General anesthesia with intravenous anesthetic propofol (2-3 mg/kg), opioid analgesic fentanyl (1-1.5 mcg/kg), and muscle relaxant rocuronium - bromide (0.6-1 mg/kg)

Intervention: General anesthesia

General anesthesia

General anesthesia with intravenous anesthetic propofol (2-3 mg/kg), opioid analgesic fentanyl (1-1.5 mcg/kg), and muscle relaxant rocuronium - bromide (0.6-1 mg/kg)

Intervention: Inguinal hernioplasty

Outcomes

Primary Outcomes

Postoperative pain

Time Frame: 5 hours

Postoperative pain level measured using the Wong-Baker Faces pain rating scale

Secondary Outcomes

  • Blood pressure(5 hours)
  • Heart rate(5 hours)

Study Sites (1)

Loading locations...

Similar Trials